Hyro Secures $45M in Growth Funding to Expand AI Agents in Healthcare

Hyro, an artificial intelligence company focused on healthcare, has successfully raised $45 million in a strategic growth round, positioning itself as the "Responsible AI Agent Platform" for the industry. This latest funding nearly doubles the company's total capital raised to date and significantly increases its valuation.
Backing from Industry Leaders
The funding round was led by Healthier Capital, a venture fund established by One Medical founder Amir Dan Rubin. Other participants included Norwest, Define Ventures, and existing client Bon Secours Mercy Health. ServiceNow Ventures, the investment arm of ServiceNow, also joined the round, underscoring the growing interest in AI-driven healthcare solutions.
Expansion of AI Capabilities
Hyro plans to utilize the new capital to accelerate the development of additional AI agents, focusing on administrative, clinical, and operational functions within healthcare systems. The company's platform is currently deployed across 45 hospital systems, serving over 30 million patients through its voice and chat interfaces.
Israel Krush, CEO and co-founder of Hyro, emphasized the company's mission, stating, "This new funding round reflects the industry's growing trust in our approach. With support from both new strategic investors and long-time partners, we're well-positioned to expand across new specialties and segments throughout the healthcare ecosystem."
Demonstrated Impact and Future Prospects
Hyro's AI agents have shown impressive results, resolving up to 85% of routine patient needs, including registration, routing, scheduling, and prescription management. The company's expansion into health plans and mid-sized clinics aligns with goals set during its December 2024 series B extension.
Amir Dan Rubin, now CEO and founding managing partner of Healthier Capital, praised Hyro's performance: "Hyro is delivering better levels of access, experience, and operational performance to leading healthcare organizations, delivering significant returns-on-investment."
As the healthcare industry continues to embrace AI technologies, Hyro's latest funding round and expansion plans signal a growing trend towards more sophisticated and integrated AI solutions in patient care and hospital operations.
References
- Hyro raises $45M growth round to expand AI agents
Championed by One Medical founder Amir Dan Rubin, the company has raised a growth round between its series B and C.
Explore Further
What are the qualifications and strategic goals of Healthier Capital and its founding managing partner Amir Dan Rubin?
Which healthcare specialties and operational segments does Hyro plan to target for expansion following this funding round?
What are the unique technical features of Hyro's AI agents that enable them to resolve up to 85% of routine patient needs?
What is Hyro's approach to entering mid-sized clinics and health plans as part of its expansion strategy?
Who are Hyro's main competitors in the AI-driven healthcare solutions space, and how does its platform compare to theirs?